Back to Results
First PageMeta Content
Cardiac imaging / Rare diseases / Cardiomyopathy / Aging-associated diseases / Medical emergencies / Cardiac magnetic resonance imaging / Glycogen storage disease type II / Echocardiography / Lysosomal storage disease / Health / Medicine / Cardiology


Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy
Add to Reading List

Document Date: 2011-02-13 00:22:26

Open Document

File Size: 304,51 KB

Share Result on Facebook

City

Hagerstown / New York / Ny Churchill Livingstone / Erlangen / Cary / Durham / Florence / /

Company

SAS Institute Inc. / Genzyme Inc. / Anaesthetic / A. Bird S.P. / M. Wasserstein S.A. / D. Bali S.A. / P.S. Kishnani / Capelle N.A. / Genzyme Corporation / Siemens Medical Solutions / Elsevier Inc. / Y.T. Chen D.D. / A.G. Elkington A.S. / /

Country

Germany / United States / /

/

Event

FDA Phase / /

Facility

National Center / Northwestern University / Duke University / Duke University Medical Center / /

/

IndustryTerm

patient / magnetic resonance imaging / online version / feasible protocol / real-time imaging / treatment for Pompe disease / cardiac magnetic resonance imaging / imaging / cine imaging / delayed enhancement imaging / therapy for infantile glycogen storage disease / cardiac imaging / delayed enhancement infarction imaging / Treatment of Pompe Disease / therapy for infantile Pompe disease / echo imaging / therapy for Pompe disease / /

MedicalCondition

viral myocarditis / ventricular tachycardia / hypertrophic cardiomyopathy / late-onset Pompe's disease / specific cardiomyopathies / infantile Pompe disease / Pediatric Heart Disease / cardiac arrhythmia / glycogen storage disease / sudden intraoperative cardiac arrest / tachycardia / Introduction Pompe disease / Different disease / infantile-onset Pompe disease / Pompe disease / symmetric hypertrophic cardiomyopathy / myocardial injury / myocardial disease / typical hypertrophic cardiomyopathy / classical infantile Pompe disease / lysosomal storage disorder / cardiac hypertrophy / cardiomyopathy / cardiopulmonary arrest / disease / perioperative cardiac arrhythmias / cardiac arrhythmias / Fabry's cardiomyopathy / thoracic/pulmonary / infantile glycogen storage disease / Fabry's disease / Fabry disease / myocardial infarction / Inherited Disease / infantile Pompe's disease / extreme hypertrophic cardiomyopathy / lysosomal storage diseases / cardiac disease / coronary artery disease / hypotonia / myocardial ischemia / /

MedicalTreatment

Mechanical ventilation / enzyme replacement therapy / relaxation / hemodialysis / cannula / /

Organization

National Institute of Health / Northwestern University / USA Duke Cardiovascular Magnetic Resonance Center / Duke University / Division of Pediatric Anesthesiology / Division of Pediatric Cardiology / FDA / Division of Medical Genetics / American Heart Association / European Union / National Center for Research Resources / Duke University Medical Center Institutional Review Board / Duke University Medical Center / /

Person

Elliott / J.A. Smeitink / Piers C.A. Barker / K. Nozaki / Raymond J. Kim / Michael J. Campbell / Jennifer S. Li / R.H. Mohiaddin / Stephen Darty / Priya S. Kishnani / Sara K. Pasquali / L. Klinge / V / A. Senthilkumar / M.H. Sketch Jr. / V / D.K. Benjamin Jr. / B. de Klerk / A. Mehta / Stephanie DeArmey / J. Pediatr / /

Position

pediatric cardiac anesthesiologist / Corresponding author / principle investigator / Representative / G.P. / D.J. / /

Product

M-16 / Myozyme / fentanyl / Lumizyme™ / /

ProvinceOrState

New York / North Carolina / /

Technology

alpha / antibodies / MRI / feasible protocol / magnetic resonance imaging / imaging protocol / /

URL

http /

SocialTag